Article Name Asia

India's SS Innovations makes history with first robotic cardiac surgery in Indonesia

SS Innovations reinforces India's position as a hub for technological innovation in healthcare using SSI Mantra...Read more

27th November, 2024


Korean startup Neurophet secures US FDA 510(k) clearance for multiple sclerosis analysis with 'Neurophet AQUA'

Accelerating global expansion with cutting-edge technology targeting multiple sclerosis, a prevalent condition in North America and Europe...Read more

25th November, 2024


Mitsubishi Electric develops compact, high-energy sub-nanosecond-pulse deep-ultraviolet laser system

Miniaturized design will support innovation in cancer treatment, drug discovery, among other diverse fields...Read more

26th November, 2024


Predictive heart monitoring startup ‘GPx’ secures new investment from NEC X; Joins Elev X! Boost Venture Studio Program

New implant and neede-Free Solution uses AI and ML to surpass accuracy of conventional heart monitoring  ...Read more

13th November, 2024


Lunit partners with VIDI group to deliver AI-powered mammography in France

Agreement to make Lunit INSIGHT MMG accessible to over 400 sites across France...Read more

13th November, 2024


SpaceGut debuts AI-driven gut health testing in Malaysia

Gut health remains a 'silent crisis' in Malaysia, with limited public awareness...Read more

13th November, 2024



Fujita Health University Haneda Clinic to introduce Tumor Portrait test by BostonGene

A comprehensive genomic test for cancer patients...Read more

21st October, 2024


Korean firms Neurophet & AriBio to develop next-gen platform for Alzheimer's diagnosis

Neurophet's brain MRI analysis technology incorporates fluid biomarker data from AriBio's global Phase 3 clinical trial for Alzheimer's disease...Read more

16th October, 2024


Japanese med tech leader Terumo announces strategic outsourcing partnership with Namsa

To help accelerate regulatory approval of Terumo's medical device portfolio on a global scale...Read more

16th October, 2024


© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer